PUBLICATION

Amotl2a interacts with the Hippo effector Yap1 and the Wnt/β-catenin effector Lef1 to control tissue size in zebrafish

Authors
Agarwala, S., Duquesne, S., Liu, K., Boehm, A., Grimm, L., Link, S., König, S., Eimer, S., Ronneberger, O., Lecaudey, V.
ID
ZDB-PUB-150904-4
Date
2015
Source
eLIFE   4: e08201 (Journal)
Registered Authors
Lecaudey, Virginie
Keywords
Amotl2, Hippo, Lef1, Yap1, developmental biology, organ size, proliferation, stem cells, zebrafish
MeSH Terms
  • Trans-Activators/metabolism*
  • Gene Expression Regulation, Developmental*
  • Transcription Factors/metabolism*
  • Cell Proliferation
  • Animals
  • Membrane Proteins/metabolism*
  • Zebrafish/genetics
  • Zebrafish/growth & development*
  • Epithelial Cells/physiology
  • Zebrafish Proteins/metabolism*
(all 10)
PubMed
26335201 Full text @ Elife
Abstract
During development, proliferation must be tightly controlled for organs to reach their appropriate size. While the Hippo signaling pathway plays a major role in organ growth control, how it senses and responds to increased cell density is still unclear. Here we use the zebrafish lateral line primordium (LLP), a group of migrating epithelial cells that form sensory organs, to understand how tissue growth is controlled during organ formation. Loss of the cell junction-associated Motin protein Amotl2a leads to overproliferation and bigger LLP, affecting the final pattern of sensory organs. Amotl2a function in the LLP is mediated together by the Hippo pathway effector Yap1 and the Wnt/β-catenin effector Lef1. Our results implicate for the first time the Hippo pathway in size regulation in the LL system. We further provide evidence that the Hippo/Motin interaction is essential to limit tissue size during development.
Genes / Markers
Figures
Figure Gallery (13 images) / 2
Show all Figures
Expression
Phenotype
Fish Conditions Stage Phenotype Figure
amotl2afu45/fu45; zf106Tgstandard conditionsPrim-25
amotl2afu45/fu45; zf106Tgstandard conditionsPrim-25
amotl2afu45/fu45; zf106Tgstandard conditionsPrim-25
amotl2afu45/fu45; zf106Tgstandard conditionsPrim-25
amotl2afu45/fu45; zf106Tgstandard conditionsLong-pec
amotl2afu46/fu46; yap1fu48/fu48; zf106Tgstandard conditionsPrim-15
amotl2afu46/fu46; yap1fu48/fu48; zf106Tg + MO3-lef1standard conditionsPrim-15
amotl2afu46/fu46; zf106Tgstandard conditionsPrim-15
amotl2afu46/fu46; zf106Tgstandard conditionsPrim-15
amotl2afu46/fu46; zf106Tgstandard conditionsPrim-15
1 - 10 of 44
Show
Mutations / Transgenics
Allele Construct Type Affected Genomic Region
fu45
    Small Deletion
    fu46
      Small Deletion
      fu47
        Small Deletion
        fu48
          Small Deletion
          ia5TgTransgenic Insertion
            pd1TgTransgenic Insertion
              t21142
                Point Mutation
                tbvbo
                  Point Mutation
                  zf106TgTransgenic Insertion
                    zf115TgTransgenic Insertion
                      1 - 10 of 10
                      Show
                      Human Disease / Model
                      No data available
                      Sequence Targeting Reagents
                      Target Reagent Reagent Type
                      amotl2aMO1-amotl2aMRPHLNO
                      amotl2aTALEN1-amotl2aTALEN
                      lef1MO3-lef1MRPHLNO
                      tp53MO4-tp53MRPHLNO
                      wwtr1MO1-wwtr1MRPHLNO
                      yap1MO1-yap1MRPHLNO
                      yap1TALEN2-yap1TALEN
                      1 - 7 of 7
                      Show
                      Fish
                      Antibodies
                      Orthology
                      No data available
                      Engineered Foreign Genes
                      Marker Marker Type Name
                      EGFPEFGEGFP
                      mCherryEFGmCherry
                      1 - 2 of 2
                      Show
                      Mapping
                      No data available